HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

Search

ConvaTec Group PLC

Atvērts

SektorsFinanšu

210.4 3.24

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

204

Max

210.8

Galvenie mērījumi

By Trading Economics

Ienākumi

-34M

71M

Pārdošana

85M

1.3B

P/E

Sektora vidējais

29.8

22.989

EPS

0.08

Dividenžu ienesīgums

3.47

Peļņas marža

5.575

Darbinieki

10,910

EBITDA

57M

338M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+44.01% upside

Dividendes

By Acuity

Dividenžu ienesīgums

Sektora vidējais

3.47%

4.69%

Nākamie ieņēmumi

2026. g. 4. aug.

Nākamais Ex dividenžu datums

2026. g. 20. aug.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-793M

4.1B

Iepriekšējā atvēršanas cena

207.16

Iepriekšējā slēgšanas cena

210.4

Ziņu noskaņojums

By Acuity

50%

50%

157 / 439 Rangs Finance

ConvaTec Group PLC Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Par ConvaTec Group PLC

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.
help-icon Live chat